Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? Article

Siker, Malika L, Chakravarti, Arnab, Mehta, Minesh P. (2006). Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? . CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 60(2), 99-111. 10.1016/j.critrevonc.2006.04.005

keywords

  • CARMUSTINE PLUS O-6-BENZYLGUANINE
  • DIAGNOSED GLIOBLASTOMA-MULTIFORME
  • GROWTH-FACTOR RECEPTOR
  • Hematology
  • Life Sciences & Biomedicine
  • MISMATCH REPAIR-DEFICIENT
  • MOTEXAFIN GADOLINIUM
  • O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
  • O-6-METHYLGUANINE DNA METHYLTRANSFERASE
  • Oncology
  • PHASE-II TRIAL
  • POLY(ADP-RIBOSE) POLYMERASE-1 INHIBITOR
  • Science & Technology
  • VINCRISTINE PCV CHEMOTHERAPY
  • anaplastic glioma
  • astrocytoma
  • chemoradiotherapy
  • chemotherapy
  • oligoastrocytoma
  • oligodendroglioma
  • radiotherapy
  • temozolomide

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 99

end page

  • 111

volume

  • 60

issue

  • 2